United States · FDA National Drug Code directory
indomethacin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-325_e729f88c-b2c8-4462-98be-7184de95b01d
- Product NDC
- 68462-325
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- indomethacin
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170622
- Source listing expiry
- 20261231
Source-listed ingredients
- INDOMETHACIN — 75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-325-01) · 68462-325-01
- 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-325-05) · 68462-325-05
- 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-325-10) · 68462-325-10
- 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-325-60) · 68462-325-60
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-325-90) · 68462-325-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →